HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 160 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,976,000 | -67.3% | 200,000 | -60.1% | 0.25% | -55.2% |
| Q3 2016 | $6,051,000 | -26.1% | 500,904 | -47.2% | 0.56% | -43.5% |
| Q2 2016 | $8,188,000 | -19.4% | 948,803 | -11.6% | 0.99% | -28.2% |
| Q1 2016 | $10,163,000 | -46.7% | 1,073,154 | -2.4% | 1.38% | -25.3% |
| Q4 2015 | $19,063,000 | +33.7% | 1,100,000 | +3.6% | 1.85% | +48.6% |
| Q3 2015 | $14,257,000 | -62.8% | 1,061,547 | -37.5% | 1.24% | -54.3% |
| Q2 2015 | $38,329,000 | +53.4% | 1,697,504 | -3.0% | 2.72% | +36.7% |
| Q1 2015 | $24,986,000 | -4.1% | 1,749,691 | -35.2% | 1.99% | +11.4% |
| Q4 2014 | $26,055,000 | +91.0% | 2,700,000 | +80.1% | 1.79% | +90.0% |
| Q3 2014 | $13,643,000 | +2.3% | 1,499,214 | +11.1% | 0.94% | +34.2% |
| Q2 2014 | $13,338,000 | – | 1,350,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |